Amphastar Pharmaceuticals : Quarterly Report for Quarter End

Table of Contents




​


UNITED STATES


SECURITIES AND EXCHANGE COMMISSION
... | August 9, 2022

Related Keywords

California , United States , State Of California , Shanghai , China , United Kingdom , Washington , Delaware , Shanxin , Jiangxi , Russia , France , Ukraine , French , Chinese , British , Russian , Jacky Zhang , Jack Zhang , El Monte , Henry Zhang , Mary Luo , Williamj Peters , Share Attributable To Amphastar Pharmaceuticals Inc , Thenasdaqstock Market , United States District Court , Amphastar France Pharmaceuticals , Mannkind Corporation , Amphastar Nanjing Pharmaceuticals Ltd , Company Chinese , Cardinal Health Inc , Drugs Initiative , Amerisourcebergen Corporation , Company French , Drug Administration , Amphastar Pharmaceuticals Inc , China Merchant Bank , Exchange Commission , Cardinal Health , Recombinant Human Insulin Research Cell Banks , Mckesson , Securities Exchange , International Medication Systems United Kingdom , Amerisourcebergen , Exchange Commission On , Astellas Pharma Us Inc , Gilead Sciences Inc , Company Annual Report On Form , Mckesson Corporation , Company Employee Stock Purchase Plan , Amphastar United Kingdom Ltd , Hanxin Pharmaceutical Technology Co Ltd , Amphastar Nanjing Pharmaceuticals Inc , Foreign Currency Exchange Risk , Party Transactions , Company Board Of Directors , Drug Enforcement Administration , Most Of The Company , Armstrong Pharmaceuticals Inc , International Medication Systems , Us Department Of Labor , Share Buyback Program , Securities Exchange Act , Interactive Data File , Regulations T , Exchange Act , Consolidated Balance Sheets , Consolidated Statements , Six Months Ended June , Comprehensive Income , Stockholder Equity , Cash Flows , Condensed Consolidated Financial , Financial Condition , Qualitative Disclosure , Equity Securities , Upon Senior , Quarterly Report , Amphastar Nanjing Pharmaceuticals , Prescription Drug Wrap Up , Patient Protection , Affordable Care Act , Annual Report , Amphastar Pharmaceuticals , Accompanying Notes , Flows From Operating Activities , Flows From Investing Activities , Flows From Financing Activities , Financing Activities , Cash Flow Information , Significant Accounting , Armstrong Pharmaceuticals , Accounting Standard Codification , Share Attributable , Employee Stock Purchase Plan , Chief Operating Decision Maker , East West Bank , Incentive Plan , Stock Purchase , Based Award Activity , Rabbi Trust , Astellas Pharma , Gilead Sciences , Dismiss Without Prejudice , Master Cell Banks , Consolidated Financial , Note About Forward Looking Statements , Condensed Consolidated Financial Statements , Months Ended June , Three Months Ended June , Supply Agreement , Cash Flow Data , South El Monte , Good Manufacturing , Investment Risk , Interest Rate Risk , Disclosure Controls , Chief Executive Officer , Chief Financial Officer , Internal Control Over Financial , Emergency Use Authorization , Complete Response Letters , Federal Food , Cosmetic Act , Drug Wrap Up , Policy Guide , New Drugs Without Approved , Compliance Policy Guide , Electronic Data Interchange , Issuer Purchases , May Yet , Manufacturing Agreement , Sarbanes Oxley Act , Principal Executive Officer , Principal Financial Officer , Extension Schema Document , Extension Calculation Linkbase Document , Extension Label Linkbase Document , Extension Presentation Linkbase Document , Extension Definitions Linkbase Document , Page Interactive File , Securities Act , Principal Financial , Accounting Officer , Nc Stock Exchange , News , Information , Press Release , Table , F , United , Securities , End , Xchange Amph Us03209r1032 ,